Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4834 Pages (Click to Jump) V   1 2 3 4 > »    
Reply to this topic

post Posted: Today, 01:12 AM
  Quote Post

Posts: 257
Thanks: 962

In Reply To: FarmaZutical's post @ Yesterday, 07:34 PM

I’ve also been patiently waiting for the results of this trial (CUV011) and it is my personal belief that Wolgen is being very strategic with the duration of the trial/release of the full results.

I had a quick look back through a few of the past AGM presentations, see graphic below, I think it’s worth re-reading what Wolgen said years ago.

I think there are some other trials that never released full results, I haven’t completed an exhaustive review however I don’t recall ever seeing final results for CUV015 - Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE).

Clinical and regulatory progress:
- European and Australian Phase III trial (CUV015) preliminary results reported December 2009; see the announcement here
- Additional European Phase III trial (CUV032) commenced in Northern Hemisphere in spring of 2010
- Safety and efficacy shown in Phase II trials
- Program deferred
Attached thumbnail(s)
Attached Image


post Posted: Today, 12:59 AM
  Quote Post

Posts: 1,421
Thanks: 1568

If this does show progress for DNA repair what are the market implications?

Does this go to a broad-based market? Or will this just be used in high-risk situations?


post Posted: Yesterday, 09:19 PM
  Quote Post

Posts: 174
Thanks: 570

In Reply To: FarmaZutical's post @ Yesterday, 07:34 PM

This leads directly into the description of the recently granted patent where it states the compounds in particular benefit immunocompromised patients (in addition to the general public).

This was a Phase II trial. Would not be surprised therefore that at some stage, hopefully soon, results will be released. There are surely other trials where information was never released - this has been going on for 13 years. Dr Dennis Wtight key person in CUV1647 study.
Attached thumbnail(s)
Attached Image


Attached File(s)
Attached File  Amended_description_with_annotations.pdf ( 46.12K ) Number of downloads: 11


Said 'Thanks' for this post: FarmaZutical  Alaaf  
post Posted: Yesterday, 07:34 PM
  Quote Post

Posts: 577
Thanks: 2370

One of the clinical trials that I have been most
interested in throughout the years is
CUV011 with 200 participants aimed to evaluate
Scenesse in AK/SCC in organ transplant recipients.

It had an end date in 2012 but results were never reported.
I’ve wondered for a long time if it was classic Clinuvel behavior
burying bad results or if there was indeed a strategic reason
for not reporting.

The principal investigator was / is Günther Hofbauer and in this article from
December, 2014 he states, that “studies are currently underway,” suggesting that
the trial was ongoing at that time.

With the renewed focus on DNA repair and general protection against skin
cancers the AK/SCC OTR trial could be a centerpiece, I think.

Was it a failure, was it a success, was it still ongoing in 2014, is it still ongoing
today, was it finished and just waiting to be published at the right moment ?
Attached thumbnail(s)
Attached Image


Said 'Thanks' for this post: PortugueseMan  IntiRaymi  waz  PunkassDerm  Alaaf  Texas T  
the near future
post Posted: Yesterday, 05:48 PM
  Quote Post

Posts: 514
Thanks: 464

In Reply To: garthyd's post @ Yesterday, 04:58 PM

As you said, it can not last

SP is a joke at the moment, very cheap

Big new investor might join the party soon

Said 'Thanks' for this post: waz  
post Posted: Yesterday, 04:58 PM
  Quote Post

Posts: 147
Thanks: 217

In Reply To: the near future's post @ Yesterday, 04:36 PM

In only a month, our 12 month low will be $21......which its pretty unfathomable to think we could be at 12 month lows after FDA approval......It can't last.

Share Cafe Sentifi Top themes and market attention on:

the near future
post Posted: Yesterday, 04:36 PM
  Quote Post

Posts: 514
Thanks: 464

In Reply To: garthyd's post @ Yesterday, 03:16 PM

Nobody is selling, rather people are buying at this low sp price

the short sellers seems that they sold most of their shares, waiting to buy back

I hope we bottomed now, and short squeese will happen with any upcoming news

Said 'Thanks' for this post: waz  Alaaf  
post Posted: Yesterday, 03:16 PM
  Quote Post

Posts: 147
Thanks: 217

Gotta be one of our lowest volume trading days in months?

Fortescue Bullro...
post Posted: Yesterday, 11:55 AM
  Quote Post

Posts: 120
Thanks: 149

Just ordered 2k at market. Very encouraged by all I am reading the last few days, and LHFUD receding in the rear view mirror. Thanks sharelooker, waz and all here.
Got them at 26.038.

Said 'Thanks' for this post: the near future  Alaaf  waz  
post Posted: Yesterday, 11:48 AM
  Quote Post

Posts: 359
Thanks: 66

Friday 6th Dec on the ASX only 50,530 of the total volume of 164,852 shares sold were short sales. Some profit taking maybe?


4834 Pages (Click to Jump) V   1 2 3 4 > » 

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.